Continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus;Tratamiento con infusión subcutánea continua de insulina en pacientes pediátricos con diabetes mellitus tipo 1

Anales de Pediatria

Volumn 64, Issue 1, 2006, Pages 21-27

  Colino Alcol, E ^a   Lopez Capape M ^a   Alvarez Gomez Ma A ^a   Alonso Blanco, M ^a   Martin Frias M ^a   Barrio Castellanos, R ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Children; Continuous subcutaneous insulin infusion; Severe hypoglycemia; Type 1 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; DIABETIC PATIENT; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; METABOLIC REGULATION; PEDIATRICS;

EID: 33644525009     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13083828     Document Type: Article

References (26)

1. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329;977-86.
2. Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, et al. Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care. 1989;12:686-93.
3. Svensson M, Eriksson J, Dahlquist G. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes. Diabetes Care. 2004;27:955-62.
4. Donaghue K, Fairchild J, Craig M, Chan A, Hing S, Cutler L, et al. Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care. 2003;26:1224-9.
5. King A, Armstrong D. A comparison of basal insulin delivery. Diabetes Care. 2003;26:1322.
6. Maniatis A, Klingesmith G, Slover R, Mowry C, Chase P. Continuous subcutaneous insulin infusion for children and adolescents: an option for routine diabetes care. Pediatrics. 2001;107:351-6.
7. Saha ME, Huuppone T, Mikael K, Juuti M, Komulainen J. Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2002;15:1005-10.
8. 1c levels across all age groups. Pediatric Diabetes. 2002;3:10-5.
9. Litton J, Rice A, Friedman N, Oden J, Lee M, Freemerk M. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr. 2002;141:490-5.
10. McMahon S, Airey L, Marangou D, McElwee K, Carne C, Clarey A, et al. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet Med. 2005;22:92-6.
11. Knight G, Jennings A, Boulton A, Tomlinson S, Ward J. Severe hyperkaliemia and ketoacidosis during routine treatment with an insulin pump. BMJ. 1985;291:371-2.
12. Raile K, Noelle V, Landgraf R, Schwarz H. Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy. J Pediatr Endocrinol Metab, 2002;15:607-12.
13. Steindel B, Roe T, Costin G, Carlson M, Kaufman F. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pr. 1995;27:199-204.
14. Kaufman FR, Halvorson M, Miller D, Mackenzie M, Fisher L, Pitukcheewanont P. Insulin pump therapy in type 1 pediatric patients: Now and into the year 2000. Diabetes Metab Res Rev. 1999;15:338-52.
15. Hanas R. Selection for and initiation of continuous subcutaneous insulin infusion. Horm Res. 2002;57 Suppl 1:101-4.
16. Bode B, Tamborlane W, Davidson P. Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents and children with diabetes. Postgrad Med. 2002;111:69-77.
17. Conrad S, McGrath M, Gitelman S. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J Pediatr. 2002;140:235-40.
18. Boland E, Grey M, Oesterle A, Fredrickson L, Tamborlane W. Continuous subcutaneous insulin infusion. Diabetes Care. 1999;22:1779-84.
19. Plotnick L, Clark L, Brancati F, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care. 2003;26:1142-6.
20. Weinzimer S, Ahern J, Doyle E, Vincent M, Dziura J, Steffen A, et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: A follow-up report. Pediatrics. 2004;114:1601-5.
21. DiMeglio L, Pottorff T, Boyd S, France L, Fineberg N, Eugster E. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr. 2004;145:380-4.
22. Wilson D, Buckingham B, Kunselman E, Sullivan M, Paguntalan H, Gitelman S. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care. 2005;28:15-9.
23. Liberatore R Jr, Perlman K, Buccino J, Artiles-Sisk A, Daneman D. Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2004;17:223-6.
24. Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial. Pediatrics. 2003;112:559-64.
25. Willi S, Planton J, Egede L, Schwarz S. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr. 2003;143:796-801.
26. 1c levels in children receiving insulin pump therapy. Pediatrics. 2004;113:e221-4.